Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

The LHCb upgrade I

The LHCb upgrade represents a major change of the experiment. The detectors have been almost completely renewed to allow running at an instantaneous luminosity five times larger than that of the previous running periods. Readout of all detectors into an all-software trigger is central to the new design, facilitating the reconstruction of events at the maximum LHC interaction rate, and their selection in real time. The experiment's tracking system has been completely upgraded with a new pixel vertex detector, a silicon tracker upstream of the dipole magnet and three scintillating fibre tracking stations downstream of the magnet. The whole photon detection system of the RICH detectors has been renewed and the readout electronics of the calorimeter and muon systems have been fully overhauled. The first stage of the all-software trigger is implemented on a GPU farm. The output of the trigger provides a combination of totally reconstructed physics objects, such as tracks and vertices, ready for final analysis, and of entire events which need further offline reprocessing. This scheme required a complete revision of the computing model and rewriting of the experiment's software

Valores de referência e influência da idade no eritrograma de fêmeas bovinas da raça Aquitânica Reference values and age effect on the erythrogram of bovine females of the Aquitanian breed

Determinaram-se os valores de referência e estudou-se a influência da idade sobre o eritrograma em fêmeas bovinas da raça Aquitânica. Amostras de sangue de 80 fêmeas bovinas, acima de 12 meses de idade, e não reagentes ao antígeno do vírus da leucose dos bovinos, foram colhidas utilizando-se EDTA como anticoagulante para realização das seguintes provas: contagem global das hemácias, determinação do volume globular, concentração de hemoglobina, cálculo dos índices hematimétricos absolutos - volume corpuscular médio (VCM), hemoglobina corpuscular média (HCM) e concentração de hemoglobina corpuscular média (CHCM). A idade exerceu influência significativa (P<0,05) sobre a maioria dos parâmetros hematológicos estudados, com diminuição da quantidade de hemácias e aumento do volume globular, quantidade de hemoglobina, VCM e HCM. Os valores foram: hemácias 6,68&plusmn;0,58&times;10(6)/mm³, volume globular 41,2&plusmn;4,5%, hemoglobina 12,8&plusmn;1,31g/dl, VCM 61,83&plusmn;6,54fl, HCM 19,28&plusmn;2,25pg, CHCM 31,4&plusmn;2,3%.<br>The reference values and the influence of the age factor on the erytrogram in bovine females of the Aquitanian breed were evaluated. Blood samples of 80 healthy females, all tested negative for bovine leucose virus, were utilized for the analysis. Erythrocyte counts, determination of the packed cell volume, concentration of hemoglobin, calculation of hematimetric absolute rates of mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) were evaluated. Significant influence (P<0.05) of age was observed for most of the hematological characteristics, with decreased of the number of erythrocytes and increase of packed cell volume, quantity of hemoglobin, MCV, MCH. The reference values were: erythrocytes counting 6.68&plusmn;0.58&times;10(6)/mm³, packed cell volume 41.2&plusmn;4.5%, hemoglobin 12.8&plusmn;1.31g/dl, VCM 61.83&plusmn;6.54fl, HCM 19.28&plusmn;2.25pg, CHCM 31.4&plusmn;2.3%